Global life science investor Novo Holdings and global investment firm KKR have signed agreements under which Novo Holdings will make a direct investment in China headquartered Sylvan, a manufacturer of fungal biotechnology…
China: Sylvan gets investment from Novo Holdings to drive further growth
…
…






